glp-1 inhibitors Medications: Everything You Need to Know Is GLP-1 Safe for Weight

doi:10.1056/NEJMoa1603827 31

Obesity and Severe Obesity Prevalence in Adults: United States, August 2021August 2023

It received FDA approval on August 22, 2008

Skeletal muscle tissue drives insulin sensitivity, supports cardiometabolic health, and plays a direct role in how efficiently your body manages blood sugar

While some of this research was funded by Novo Nordisk (the maker of Ozempic, Wegovy, Saxenda, and Victoza), the results are clearpeople on semaglutide lost nearly twice as much weight and hit the 5-percent weight-loss milestone in half the time

But patients are: Suffering from autoimmune disease NOW Struggling with PCOS NOW Fighting addiction NOW Accumulating visceral fat in midlife NOW Developing cardiovascular disease and cognitive decline NOW Were offering them: A biologically plausible intervention With an excellent safety profile at low doses Under careful monitoring With full disclosure of evidence limitations The prosecution is offering them: A decade of continued suffering While we wait for studies that pharmaceutical companies wont fund Because theres no profit in proving generic semaglutide works at 0.15 or 0.25 mg for off-label indications